Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Enzalutamide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02676986
What this trial is testing

Short-term Preoperative Treatment With Enzalutamide, Alone or in Combination With Exemestane in Primary Breast Cancer

Who this might be right for
Primary Breast Cancer ER+vePrimary Breast Cancer AR+ve TNBN
Queen Mary University of London 221
Testing effectiveness (Phase 2)Study completedNCT03464201
What this trial is testing

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study

Who this might be right for
Ovarian Cancer
Grupo Español de Tumores Huérfanos e Infrecuentes 16
Testing effectiveness (Phase 2)Study completedNCT05081193
What this trial is testing

Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Castration-resistant Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Study completedNCT02007512
What this trial is testing

Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 247
Large-scale testing (Phase 3)UnknownNCT01949337
What this trial is testing

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
Alliance for Clinical Trials in Oncology 1,311
Testing effectiveness (Phase 2)Study completedNCT04332744
What this trial is testing

Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)

Who this might be right for
Metastatic Prostate Cancer
MedSIR 54
Large-scale testing (Phase 3)Study completedNCT00974311
What this trial is testing

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

Who this might be right for
Castration-Resistant Prostate Cancer
Pfizer 1,199
Testing effectiveness (Phase 2)Active Not RecruitingNCT04471974
What this trial is testing

ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaMetastatic Prostate Small Cell Carcinoma+3 more
Rahul Aggarwal 61
Large-scale testing (Phase 3)Active Not RecruitingNCT06551324
What this trial is testing

Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer 600
Post-approval studies (Phase 4)Study completedNCT03927391
What this trial is testing

Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Radboud University Medical Center 57
Testing effectiveness (Phase 2)Study completedNCT02799745
What this trial is testing

Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Prostate Cancer
Astellas Pharma Global Development, Inc. 227
Early research (Phase 1)Ended earlyNCT03150056
What this trial is testing

Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 73
Testing effectiveness (Phase 2)Study completedNCT02199197
What this trial is testing

Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Utah 49
Large-scale testing (Phase 3)Study completedNCT01212991
What this trial is testing

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Pfizer 1,717
Very early researchEnded earlyNCT02885649
What this trial is testing

Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage I Renal Cell Cancer
Rutgers, The State University of New Jersey 3
Early research (Phase 1)Study completedNCT00510718
What this trial is testing

MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer

Who this might be right for
Prostate CancerHormone Refractory Prostate Cancer
Pfizer 140
Testing effectiveness (Phase 2)Active Not RecruitingNCT04655365
What this trial is testing

Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 50
Testing effectiveness (Phase 2)Study completedNCT02453009
What this trial is testing

Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Santa Chiara Hospital 246
Testing effectiveness (Phase 2)Study completedNCT03860987
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer

Who this might be right for
Castrate Sensitive Prostate Cancer
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)Study completedNCT02711956
What this trial is testing

ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Zenith Epigenetics 75
Next Page